Press release
Key Factor Supporting Global Theranostics Market Development in 2025: Rising Cancer Prevalence Fuels Growth In The Theranostics Market
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.How Large Will the Theranostics Market Size By 2025?
The overall scale of the theranostics sector has experienced swift expansion lately, charting an increase from a valuation of $111.1 billion in 2024 to an anticipated $122.98 billion by 2025, reflecting a compound annual growth rate (CAGR) of 10.7%; this expansion observed during the preceding years is fundamentally linked to progress in molecular imaging techniques, the increasing adoption of value-driven healthcare frameworks, and its incorporation within cancer treatment protocols.
How Big Is the Theranostics Market Size Expected to Grow by 2029?
Projections indicate that the theranostics market is poised for swift expansion over the forthcoming years, reaching a valuation of $184.94 billion by 2029, fueled by a compound annual growth rate (CAGR) of 10.7%. This projected increase throughout the forecast duration stems from several key factors, such as the proliferation of precision medicine efforts, widening utility beyond cancer treatment, demographic shifts toward an older population facing more chronic illnesses, breakthroughs in identifying biomarkers, and augmented backing and financing from governmental bodies. Regarding significant shifts expected in the market during this time frame, these encompass growing regulatory endorsement, the ascent of associated diagnostic tools, a heightened emphasis specifically on theranostics within oncology, greater involvement and understanding among patients, and the melding of different technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report
Which Key Market Drivers Powering Theranostics Market Expansion and Growth?
The escalating incidence of cancer is anticipated to be a primary catalyst for the expansion of the theranostics sector moving ahead. Uncontrolled cellular proliferation characterizes cancer, profoundly affecting numerous bodily systems and accounting for substantial global illness and fatality rates. Theranostics, which merges diagnostic methodologies with therapeutic interventions, demonstrates considerable promise, particularly in addressing cancer and long-term conditions. This methodology facilitates bespoke, focused interventions by consolidating the abilities to identify and treat ailments, thus opening avenues for breakthroughs within the medical field. Consequently, the growing pool of individuals diagnosed with cancer is directly fueling the market for theranostics. As a concrete example illustrating this trend, data released in January 2022 by the National Cancer Institute (NCI)-a US federal entity under the National Institutes of Health (NIH) solely focused on cancer research, prevention efforts, and care-indicated that roughly 5.4 percent of the American populace, translating to 18.1 million persons, have successfully survived cancer. Furthermore, concerning advanced-stage disease, the population living with metastatic forms of breast, prostate, lung, colorectal, or bladder cancer, alongside metastatic melanoma, stood at 623,405 in the year 2022, with projections showing an ascent to 693,452 individuals by 2025, solidifying the assertion that the expanding burden of cancer is the impetus behind theranostics market growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Theranostics Market?
Leading entities within the theranostics market are prioritizing the creation of sophisticated technological offerings, exemplified by theranostics clinical trials, with the goal of advancing tailored medical care and elevating patient results through the unified application of diagnostic and therapeutic modalities. These clinical research endeavors specifically investigate how combining diagnostic procedures with precisely targeted therapeutic agents can customize treatment plans for unique individuals, assessing treatment efficacy determined by patient-specific biological markers to thereby foster greater personalization in healthcare. A relevant illustration occurred in May 2024 when BAMF Health, a provider of cancer treatments situated in the United States, initiated the COMBAT Trial, formally named "A Phase I/II Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617" (NCT05633160); this trial is distinguished by its swift initiation, achieved in a mere seven weeks thanks to BAMF Health's BAMF RapAct program, and its concentration on employing novel radiopharmaceuticals designed to bind with the Gastrin-Releasing Peptide receptor (GRPR), seeking to broaden therapeutic alternatives for patients facing restricted treatment choices.
What Are the Emerging Segments in the Theranostics Market?
The theranosticsmarket covered in this report is segmented -
1) By Disease Type: Neurological Disorders; Cardiovascular Diseases; Immunological Disorders; Oncology Diseases; Other Diseases
2) By Technology: Polymerase Chain Reaction; Immunohistochemistry; In-Situ Hybridization; Sequencing; Other Technologies
3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Neurological Disorders: Alzheimer's Disease; Parkinson's Disease; Multiple Sclerosis; Epilepsy; Other Neurological Disorders
2) By Cardiovascular Diseases: Coronary Artery Disease; Heart Failure; Atrial Fibrillation; Hypertension; Other Cardiovascular Diseases
3) By Immunological Disorders: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Inflammatory Bowel Disease; Psoriasis; Other Immunological Disorders
4) By Oncology Diseases: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Other Oncology Diseases
5) By Other Diseases: Infectious Diseases; Metabolic Disorders; Genetic Disorders; Other Diseases
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10823&type=smp
Who Are the Global Leaders in the Theranostics Market?
Major companies operating in the theranostics market include Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc, Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Helmholtz Centre for Infection Research, Radiopharm Theranostics Ltd, Alpha- Theranostics, UNIVERZITET U NOVOM SADU, Cardio-Theranostics LLC, Curium, SoFi Technologies Inc., Theradiag, Cell Theranostics, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc, Qiagen NV, Foundation Medicine Inc, Leica Biosystems Nussloch GmBH, Pfizer Inc., Siemens Healthineers, Advanced Accelerator Applications, AstraZeneca plc, Bayer AG, Bio-Rad Laboratories, The Bristol-Myers Squibb Company, Danaher Corporation, MilliporeSigma, Illumina Inc., Merck KGaA, Roche Diagnostics Corporation, PerkinElmer Inc.
Which are the Top Profitable Regional Markets for the Theranostics Industry?
North America was the largest region in the global theranostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10823
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Factor Supporting Global Theranostics Market Development in 2025: Rising Cancer Prevalence Fuels Growth In The Theranostics Market here
News-ID: 4272479 • Views: …
More Releases from The Business Research Company
Synthetic Fibers Market Report Examines Market Dynamics, Segment Insights And Co …
The synthetic fibers industry is set to experience consistent expansion over the coming years, driven by advancements in various sectors and growing demand for specialized materials. This market is evolving rapidly, influenced by technological progress and shifting consumer preferences, which together are shaping its future trajectory.
Projected Market Size and Growth Outlook for Synthetic Fibers
The synthetic fibers market is anticipated to reach a value of $160.58 billion by 2030,…
Sustainable Plastic Packaging Market Analysis And Forecast Report Featuring Key …
The sustainable plastic packaging sector is gaining significant traction as the demand for eco-friendly packaging solutions rises globally. With increasing environmental awareness and a push towards reducing plastic waste, this market is set to witness impressive expansion in the coming years. Let's explore the market's growth outlook, key players, driving factors, prevailing trends, and its segmentation in detail.
Sustainable Plastic Packaging Market Size Forecast Through 2030
The sustainable plastic packaging…
Superparamagnetic Particles Industry Analysis Report 2026: Key Trends, Drivers, …
The superparamagnetic particles market is poised for significant expansion in the coming years, driven by advancements in medical technology and growing applications across healthcare and research fields. This report delves into the market's expected growth trajectory, key players, emerging innovations, and critical segments shaping its future.
Projected Market Value and Growth Rate for Superparamagnetic Particles
The superparamagnetic particles market is anticipated to grow rapidly, reaching a valuation of $2.43 billion…
Sulfuric Acid Market Anticipated to Grow at 8.7% CAGR Through 2030: Industry Rep …
The sulfuric acid market is on track for significant expansion over the coming years, driven by rising industrial demand and technological advancements. This growth is closely linked to various sectors such as electric vehicle batteries and metal recycling, which are increasingly relying on high-quality sulfuric acid. Let's explore the current market size, key industry players, emerging trends, and the major segments shaping this market.
Sulfuric Acid Market Valuation and Growth Outlook…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
